Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid
被引:46
作者:
Matsui, M
论文数: 0引用数: 0
h-index: 0
机构:
Saitama Med Sch, Dept Microbiol, Moroyama, Saitama 3500495, JapanSaitama Med Sch, Dept Microbiol, Moroyama, Saitama 3500495, Japan
Matsui, M
[1
]
Moriya, O
论文数: 0引用数: 0
h-index: 0
机构:
Saitama Med Sch, Dept Microbiol, Moroyama, Saitama 3500495, JapanSaitama Med Sch, Dept Microbiol, Moroyama, Saitama 3500495, Japan
Moriya, O
[1
]
Akatsuka, T
论文数: 0引用数: 0
h-index: 0
机构:
Saitama Med Sch, Dept Microbiol, Moroyama, Saitama 3500495, JapanSaitama Med Sch, Dept Microbiol, Moroyama, Saitama 3500495, Japan
Akatsuka, T
[1
]
机构:
[1] Saitama Med Sch, Dept Microbiol, Moroyama, Saitama 3500495, Japan
hepatitis C virus;
the prime-boost immunization;
interleukin-12;
D O I:
10.1016/S0264-410X(02)00704-1
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
We evaluated the prime-boost immunization consisting of hepatitis C virus (HCV)-core expression plasmid (pCEP4-core) and replication-defective adenovirus expressing HCV-core (Adex1SR3ST) for core-specific CTL induction in mice. Compared to a single booster, double boosters after priming enhance CTL induction. The prime-double boosts immunization involving pCEP4-core priming followed by pCEP4-core and Adex1SR3ST boostings (pC/pC/aC) can induce core-specific CTLs as well as other combinations: pC/aC/aC; aC/pC/pC; aC/aC/aC, whereas pC/pC/pC does not induce CTLs. Furthermore, co-administration of interleukin-12 (IL-12) expression plasmid leads to the highly efficient CTL induction and clearance of HCV-core expressing vaccinia virus challenged. Thus, the prime-double boosts immunization together with IL-12 may be promising for HCV vaccine. (C) 2002 Elsevier Science Ltd. All rights reserved.